Best Practices for the Integration of Continuous Glucose Monitoring Devices Across Community Pharmacy Settings

Add-on activity

This activity includes interactive patient counseling video vignettes.

Program Description

Despite the growing body of data supporting continuous glucose monitoring (CGM) devices as the new standard of care for diabetes management, their uptake remains low. Navigating access, understanding data, and integrating CGM into daily routines can be challenging for patients and present opportunities for pharmacist involvement. Community pharmacists are well positioned to identify patients who could benefit from CGM use. In this panel discussion, faculty experts will share strategies to initiate conversations about CGM use with people living with diabetes and tips for helping them access CGM technology. The importance of collaboration between pharmacists, primary care physicians, and other diabetes educators in supporting patients throughout their CGM journey; troubleshooting technical issues; interpreting data; and ensuring successful CGM integration into daily diabetes management will be shared.

Target audience: Health-system and retail pharmacists

Type of activity: Application
Release date: September 27, 2024
Expiration date: September 27, 2025

Time to complete activity: 1.5 hours

Learner level: Foundational, Intermediate
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Identify patients who would benefit from using a continuous glucose monitoring (CGM) device to improve the management of diabetes
• Employ best practices across community pharmacy settings for successfully integrating CGM
• Maximize reimbursement opportunities for CGM support and education for pharmacists’ services related to data interpretation, initiation of CGM, and patient counseling

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity number 0290-0000-24-271-H01-P. The activity is available for CE credit through September 27, 2025.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Susan Cornell, PharmD, CDCES, FAPhA, FADCES, has the following financial relationships with commercial interests to disclose:

Consultant: Advisory Board for Novo Nordisk, Inc

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Robert Nichols, PharmD, BCPS

Vivian Nnacho Ayuk, PharmD, CDCES

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Rose Namissa-Buszka, PharmD, BCPS, CHCP; Aleksandra Thomas; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green have no relevant financial relationships with commercial interests to disclose.

Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms